Painful periods affect the majority of women, and the usual response comes down to two options: an anti-inflammatory, or hormonal contraception. Between the two, the range of natural remedies is vast and rarely documented. Ginger is an exception.
It is one of the very rare supplements to have been tested against placebo on multiple occasions, to appear in a Cochrane review with more than one trial, and to have been compared directly to ibuprofen. This article presents this data with its limitations, which are real, and draws a boundary that few articles on the subject bother to establish: that between ordinary menstrual pain and pain that signals something else.
Against placebo. Three independent meta-analyses converge: pain reduction of 1.85 points on the visual scale in the first, of 1.55 points in the Cochrane review on three trials and 266 women, of 2.90 points in the third. Level of evidence weak, consistent direction.
Against anti-inflammatories. In 150 female students, 250 mg of ginger four times a day for three days performed as well as ibuprofen and mefenamic acid, with no difference in severity, relief, or satisfaction. The protocol studied: 750 to 2,000 mg per day, for the first three to four days of the cycle. The red line: all of this concerns primary dysmenorrhea. Pain that worsens, extends beyond the menstrual period, or resists anti-inflammatory medications warrants a medical diagnosis, not a supplement.
Primary or secondary: the distinction that comes first
<<<34>>> Dysmenorrhea dysménorrhée is divided into two categories that have neither the same cause nor the same management approach.
| Primary dysmenorrhea | Secondary dysmenorrhea | |
|---|---|---|
| Cause | Uterine contractions and inflammatory mediators of the cycle, with no underlying disease | An underlying pathology: endometriosis, adenomyosis, fibroids, infection |
| Beginning | From the first years after the first menstrual period | Often later, or worsening of an existing pain |
| Timeline | First or first two days of menstruation | Often extends before and after, sometimes throughout the entire cycle |
| Response to anti-inflammatory medications | Generally good | Often insufficient |
| What this article covers | Yes : all trials focus on this form | No : falls under medical diagnosis |
Endometriosis takes several years on average to be diagnosed, partly because the pain is long considered "normal." A remedy that slightly alleviates pain without treating the cause can delay this diagnosis. This is the real risk of this topic, far more so than the side effects of ginger.
The rule is simple: the data that follows applies to pain that resembles what it has always been, limited to the first days of menstruation, and that responds to anti-inflammatory medications. Anything that deviates from this should be discussed with a doctor first.
Against placebo: three meta-analyses
What makes ginger's file unusual in the field of natural remedies is that it has been synthesized three times, by different teams, with the same result.
| Meta-analysis | What it includes | Result versus placebo |
|---|---|---|
| Pain Medicine, 2015 | 4 randomized trials, ginger for the first 3 to 4 days of the cycle | Pain reduced by 1.85 points on the visual scale, p = 0.0003 |
| Cochrane Review, 2016 | 3 trials, 266 women, in a review of 27 trials on all supplements | Pain reduced by 1.55 points ; relief 5.4 times more likely in one trial |
| J Int Med Res, 2020 | Ginger among three plants, 9 trials and 647 women total | Pain reduced by 2.90 points, the most marked effect of the three plants |
On a pain scale from 0 to 10, a decrease of 1.5 to 2 points is an effect moderate and clinically perceptible. It's not a disappearance of pain; it's a real reduction.
The first author of the 2015 meta-analysis is affiliated with a dietary supplement manufacturer. We point this out because it's fair. The reason not to stop there is that his result is confirmed by the Cochrane review, independent and methodologically the most demanding, and by a third team with no connection to the first. When three syntheses with different affiliations converge, it's the convergence that establishes credibility, not one of the three.
The Cochrane review nevertheless qualifies all this evidence as low or very low quality, for the reasons detailed in section 4. Convergent does not mean solid.
Versus ibuprofen: the comparative trial
Beating placebo is one thing. Measuring up to the reference treatment is another, and that's what an Iranian trial published in 2009 did.
150 female students aged 18 and over, with primary dysmenorrhea, were divided into three equal groups receiving, starting on the first day of menstruation and for three days, four times daily:
- 250 mg of ginger rhizome powder, or 1,000 mg per day;
- 250 mg of mefenamic acid, a conventional anti-inflammatory for dysmenorrhea;
- 400 mg of ibuprofen.
After one cycle, the severity of dysmenorrhea had decreased in all three groups, and no difference was found between them, neither in severity, nor in relief, nor in satisfaction. No severe adverse effects were reported. The authors conclude that ginger was as effective as both anti-inflammatories.
This trial is double-blind, which is a strong point. But the allocation of participants was done by alternation, not by strict randomization, which weakens the comparison. It covered only a single cycle. Pain was assessed using a verbal scale, less precise than a visual scale. And 50 women per group is a sample size that may fail to detect a moderate difference between treatments.
What this trial establishes is that ginger did not perform worse than ibuprofen under these conditions. It does not prove equivalence in the strict sense. It's already remarkable for a rhizome powder, and that's all that needs to be said about it.
What the Cochrane review adds, and detracts
The Cochrane review on dietary supplements in dysmenorrhea examined 27 trials and 3,101 women, covering twelve plants and five non-plant-based supplements. It is the most rigorous source in the report, and what it says applies to ginger as much as to all the others.
What it adds
- Ginger is one of the rare supplements to have multiple trials in the review, three, whereas most have only one.
- Its effect compared to placebo, 1.55 points less on pain, is classified among "limited evidence of efficacy," alongside fenugreek, vitamin B1, and zinc sulfate.
- Compared to zinc sulfate in a trial of 101 women, it showed no difference: both performed equally.
What it removes
- All evidence on supplements in dysmenorrhea is of low or very low quality, because of very small sample sizes, poorly reported methods, and inconsistencies between trials.
- No supplement, ginger included, has high-quality evidence.
- Only four trials out of 27 reported adverse effects in both groups: safety data is therefore very sparse.
- 22 of the 27 trials were conducted in Iran, among female students in late adolescence and early adulthood. This is a homogeneous population, and generalization to other ages and contexts is not automatic.
Dose, timing, and duration: what was studied
| Parameter | What the trials did | What this implies |
|---|---|---|
| Daily dose | 750 to 2,000 mg of rhizome powder, in multiple doses; 1,000 mg in the trial against ibuprofen | A narrow and consistent range, in multiple doses spread throughout the day |
| Timing | From the first day of menstruation in most trials, one to two days before in some | The window is the beginning of cycle, as with anti-inflammatory drugs: act early |
| Duration | Three to four days | One use occasional, not continuous intake throughout the month |
| Form | Rhizome powder in capsules | The only form that allows a known dose ; infusion does not provide this |
| Monitoring | One to three cycles | The effect is evaluated over the current cycle ; without improvement after one or two cycles, persisting has no scientific basis |
A clarification oninfusion, the most common form: it provides a highly variable amount of ginger and generally lower than the doses used in trials. It may be suitable for mild discomfort, but it does not correspond to the protocols that produced the results described here. The question of form is detailed in our article onginger lemon infusion.
The limitations you need to know
- Study population. Young female students, with no medical conditions, mostly from the same country. A 40-year-old woman, a 14-year-old teenager, or a woman with endometriosis is not represented.
- Association with an anti-inflammatory drug. No trial has studied this. Both act on similar pathways, making the combination plausible but undocumented.
- Comparison with hormonal treatments. Never conducted. Ginger is not a substitute for contraception prescribed for pain management.
- Repeated use over years. Not specifically evaluated, even though ginger is a common food.
- Interactions. Ginger is typically flagged with anticoagulants and antiplatelet agents. Our article on dangers and contraindications addresses this.
Pain that worsens from cycle to cycle. Pain that extends extension of the menstrual period. Pain that appears for the first time after age 25, or that changes in nature. Pain that resists anti-inflammatory medication. Pain during sexual intercourse, bowel movements, or urination. Heavy or irregular bleeding. Difficulty conceiving. Each of these signs suggests secondary dysmenorrhea, and the answer is a diagnosis, not a supplement.
What to do in practice
Frequently Asked Questions
Efficacy
Does ginger relieve painful periods?
Against placebo, yes, and three independent meta-analyses converge. The first, covering four randomized trials, found a reduction of 1.85 points on the visual pain scale. The Cochrane review on supplements for dysmenorrhea found a reduction of 1.55 points across three trials and 266 women. A third meta-analysis found a reduction of 2.90 points. The level of evidence remains weak, but the direction is consistent.
Is ginger as effective as ibuprofen?
In the only direct comparison trial, yes. In 150 female students with primary dysmenorrhea, 250 mg of ginger powder four times daily for three days was compared to 250 mg of mefenamic acid and 400 mg of ibuprofen, using the same protocol. At the end of one cycle, there was no difference between the three groups in severity, pain relief, or satisfaction. This trial has limitations—only one cycle, alternating assignment—but its result is notable.
Is the evidence solid?
It is convergent but of low quality, and the Cochrane review states it plainly: all evidence on supplements for dysmenorrhea is of low or very low quality, due to small sample sizes, poorly reported methods, and inconsistencies. No supplement has high-quality evidence. Ginger is among the best placed on the list, with three trials in Cochrane where most have only one, but this remains a modest level of evidence.
Who were these studies conducted on?
Essentially on female students in late adolescence and early adulthood, with primary dysmenorrhea, and the Cochrane review notes that 22 of the 27 included trials were conducted in Iran. This is a young population with no identified pathology, in a particular cultural and dietary context. The results do not automatically transfer to a 40-year-old woman or to secondary dysmenorrhea.
Are there conflicts of interest in these studies?
The first author of the 2015 meta-analysis is affiliated with a dietary supplement manufacturer. We report this because it is fair to do so, while noting that his results are confirmed by the independent Cochrane review and by a third meta-analysis. The convergence of three sources with different affiliations is what makes the result credible.
Is ginger as effective as cinnamon or fennel?
One meta-analysis compared all three against placebo: cinnamon, fennel, and ginger all reduced pain intensity, ginger with the most marked effect on this measure, and cinnamon also shortened pain duration. These plants have not been directly compared to each other in robust trials, and the Cochrane review judges all this evidence to be of low quality.
Dosage and Use
What dose was studied?
The reference meta-analysis retained doses of 750 to 2,000 mg of ginger powder per day, during the first three to four days of the cycle. The trial comparing ginger to anti-inflammatories used 1,000 mg daily in four 250 mg doses. These protocols share one point: ginger is taken at the start of menstruation, for a few days, not continuously all month.
Should you start before your period?
The trials mostly started on the first day of menstruation, for three to four days. Some protocols tested starting one or two days before. The logic is that of anti-inflammatories: act on pain mediators as soon as they appear rather than after pain is established. What is established is the window of early cycle; the timing details remain to be clarified by dedicated trials.
How long before it works?
The trials measure pain over the current cycle, meaning the effect is expected within hours and days following intake, not after weeks of treatment. If nothing changes over one or two cycles at the studied dose, persisting has no basis in the data, and the question of another cause of pain arises.
Fresh, infusion, or capsules: which form?
The trials used rhizome powder in capsules at defined doses. This is the only form that allows you to know what you're taking and stay within the studied range. An infusion of fresh ginger provides a highly variable and generally lower amount. It may suit mild discomfort, but it does not match the trial protocols.
Can you take it each cycle?
The trials covered one to three cycles. The safety of repeated use over years, three to four days per month, has not been specifically evaluated, even though ginger is a common food. The reasonable approach is to discuss it with a professional if use becomes regular, and to reconsider the cause of pain if it persists or worsens.
At what age can you start?
The trials included women 18 and older. In younger adolescents, who are nonetheless the most affected by primary dysmenorrhea, data are lacking, and this question falls to a physician or midwife, particularly to rule out a secondary cause from the first painful cycles.
Safety and Interactions
Does ginger have side effects?
In the comparison trial, no severe adverse effects were reported, but the Cochrane review emphasizes that only four of the 27 trials on supplements reported adverse effects in both groups, making any safety conclusion fragile. Known effects of ginger are digestive—heartburn, discomfort—at high doses. Our article on dangers and contraindications provides complete details.
Can you combine ginger and anti-inflammatory medication?
No trial has studied this combination. Ginger and non-steroidal anti-inflammatories act on similar pathways, those of prostaglandins, making addition plausible but undocumented. If you take any medication, including over-the-counter, this question should be raised with your pharmacist or physician, particularly in case of anticoagulant therapy.
Does ginger replace the pill or hormonal treatment?
No. Hormonal contraceptives act on the cycle itself and are one of the two conventional reference options, along with anti-inflammatories. Ginger has been compared to anti-inflammatories, never to hormonal treatments, and does not substitute for them. If hormonal treatment has been prescribed to you, there is no question of replacing it with a supplement.
Does ginger work on other menstrual symptoms?
The trials measured pain, and the author of the comparison trial explicitly calls for studying other symptoms. Data on ginger for nausea come from other contexts, notably pregnancy. On bloating, fatigue, or mood during menstruation, we have not identified a specific trial.
When to Consult
What is the difference between primary and secondary dysmenorrhea?
Primary dysmenorrhea is menstrual pain without underlying disease, related to uterine contractions and inflammatory mediators of the cycle. Secondary dysmenorrhea is pain caused by a pathology: endometriosis, adenomyosis, fibroids, infection. All ginger trials focus on the primary form. Nothing in this article applies to pain of pathological origin, which requires a diagnosis.
What signs should prompt a consultation?
Pain that worsens from cycle to cycle, that extends well beyond the menstrual period, that appears for the first time after age 25, that resists anti-inflammatory drugs, that is accompanied by pain during intercourse, defecation or urination, very heavy or irregular bleeding, or difficulty conceiving. These are signs suggestive of an underlying cause, and ginger is not the answer: consultation is.
What should you know about ginger and painful periods?
That three meta-analyses converge on a real effect versus placebo, with weak level of evidence. That one trial places it on equal footing with ibuprofen and mefenamic acid. That the studied protocols are 750 to 2,000 mg per day, during the first three to four days of the cycle. That this applies only to primary dysmenorrhea. And that pain that worsens, extends beyond the menstrual period, or resists anti-inflammatory drugs is a matter for medical consultation, not supplementation.
Glossary
- Dysmenorrhea
- Medical term designating menstrual pain.
- Primary dysmenorrhea
- Menstrual pain without underlying pathology, related to uterine contractions and inflammatory mediators of the cycle.
- Secondary dysmenorrhea
- Menstrual pain caused by an identifiable pathology: endometriosis, adenomyosis, fibroids, infection.
- Endometriosis
- Presence of tissue similar to the uterine lining outside the uterus, a frequent cause of secondary dysmenorrhea and diagnostic delay.
- Nonsteroidal anti-inflammatory drug
- Class of medications, including ibuprofen and mefenamic acid, acting on prostaglandins, the standard treatment for primary dysmenorrhea.
- Prostaglandins
- Inflammatory mediators produced by the uterine lining, responsible for contractions and menstrual pain.
- Visual analog scale
- A scale from 0 to 10 on which the person rates the intensity of their pain, the standard measurement in trials.
- Meta-analysis
- Statistical pooling of results from multiple trials to estimate an overall effect.
Sources
The studies cited below were identified via PubMed.
- Daily JW, Zhang X, Kim DS, Park S. Efficacy of ginger for alleviating symptoms of primary dysmenorrhea: a systematic review and meta-analysis of randomized clinical trials. Pain Medicine, 2015;16(12):2243-2255. First author affiliated with a dietary supplement manufacturer. DOI
- Pattanittum P, et al. Dietary supplements for dysmenorrhea. Cochrane Database of Systematic Reviews, 2016;(3):CD002124. DOI
- Xu Y, Yang Q, Wang X. Efficacy of herbal medicine (cinnamon, fennel, ginger) in primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Journal of International Medical Research, 2020;48(6). DOI
- Ozgoli G, Goli M, Moattar F. Comparison of the effects of ginger, mefenamic acid and ibuprofen on pain in women with primary dysmenorrhea. Journal of Alternative and Complementary Medicine, 2009;15(2):129-132. DOI
